Fallopian Tube

7 clinical trials · Condition

Record	Firm	Date
TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT05053750)	M.D. Anderson Cancer Center	2021-12-14
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT04606914)	University of Alabama at Birmingham	2021-05-27
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer (NCT03245892)	Memorial Sloan Kettering Cancer Center	2017-08-04
A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer (NCT02737787)	Memorial Sloan Kettering Cancer Center	2016-04-01
Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies (NCT01974765)	Memorial Sloan Kettering Cancer Center	2013-11-05
Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer (NCT01826227)	Memorial Sloan Kettering Cancer Center	2013-03-01
Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT01339650)	AbbVie (prior sponsor, Abbott)	2011-05-06

Track Fallopian Tube automatically

Every clearance here is in the API, with alerts when new ones post.